We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Lists of possible susceptible and vector species, that are referenced in aquatic animal health legislation and import health certificates.
This guidance only applies to movements of bluetongue susceptible animals. Non-susceptible animals may attend shows as normal.
In the event of a bluetongue outbreak, controls will be imposed to prevent the spread of disease via semen, ova and embryos from bluetongue-susceptible animals.
Paper prepared by academics.
Specialist reference laboratory services for mycobacteriology available in the UK.
Paper on susceptibility and transmission in children prepared for the Scientific Advisory Group for Emergencies (SAGE).
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved (27 December 2024) the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH).
If you keep bluetongue-susceptible livestock, you should consider voluntarily testing these animals to demonstrate they remain free from bluetongue disease.
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).